BioPharma Credit (LON:BPCP) Reaches New 12-Month High – What’s Next?

BioPharma Credit PLC (LON:BPCP – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday. The company traded as high as GBX 75.40 and last traded at GBX 75.40, with a volume of 44,492 shares. The stock had previously closed at GBX 73.60.

BioPharma Credit Stock Up 2.4%

The stock’s fifty day moving average is GBX 72.92 and its two-hundred day moving average is GBX 71.25. The firm has a market capitalization of £1.04 billion, a price-to-earnings ratio of 11.14 and a beta of 0.18.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Further Reading

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.